Jure Murgić

1.2k total citations
53 papers, 400 citations indexed

About

Jure Murgić is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiation. According to data from OpenAlex, Jure Murgić has authored 53 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 12 papers in Radiation. Recurrent topics in Jure Murgić's work include Prostate Cancer Treatment and Research (20 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Advanced Radiotherapy Techniques (12 papers). Jure Murgić is often cited by papers focused on Prostate Cancer Treatment and Research (20 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Advanced Radiotherapy Techniques (12 papers). Jure Murgić collaborates with scholars based in Croatia, Canada and United States. Jure Murgić's co-authors include Zvonko Kusić, Hans T. Chung, Alejandro Berlín, Ananth Ravi, Gerard Morton, Masoom A. Haider, Matt Wronski, Melanie Davidson, Andrew Loblaw and Melvin L.K. Chua and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Jure Murgić

50 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jure Murgić Croatia 10 254 112 92 66 56 53 400
Pervin Hürmüz Türkiye 12 239 0.9× 89 0.8× 109 1.2× 61 0.9× 28 0.5× 55 381
Palak Popat India 11 242 1.0× 116 1.0× 61 0.7× 74 1.1× 30 0.5× 47 419
Ryan J. Burri United States 12 396 1.6× 178 1.6× 145 1.6× 88 1.3× 69 1.2× 16 570
Paul Rogowski Germany 11 276 1.1× 86 0.8× 178 1.9× 62 0.9× 40 0.7× 36 420
Priyamvada Maitre India 9 316 1.2× 158 1.4× 86 0.9× 34 0.5× 23 0.4× 51 425
Douglas A. Murrey United States 9 130 0.5× 82 0.7× 199 2.2× 80 1.2× 59 1.1× 21 408
Tanja Baresic Italy 12 461 1.8× 87 0.8× 281 3.1× 79 1.2× 23 0.4× 20 601
Daniele Scartoni Italy 9 212 0.8× 82 0.7× 110 1.2× 76 1.2× 44 0.8× 45 351
Waqar Haque United States 11 149 0.6× 48 0.4× 68 0.7× 43 0.7× 22 0.4× 19 325
Meryem Brihoum France 8 414 1.6× 115 1.0× 49 0.5× 54 0.8× 47 0.8× 12 470

Countries citing papers authored by Jure Murgić

Since Specialization
Citations

This map shows the geographic impact of Jure Murgić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jure Murgić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jure Murgić more than expected).

Fields of papers citing papers by Jure Murgić

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jure Murgić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jure Murgić. The network helps show where Jure Murgić may publish in the future.

Co-authorship network of co-authors of Jure Murgić

This figure shows the co-authorship network connecting the top 25 collaborators of Jure Murgić. A scholar is included among the top collaborators of Jure Murgić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jure Murgić. Jure Murgić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murgić, Jure, et al.. (2024). Exploring potential therapeutic combinations for castration-sensitive prostate cancer using supercomputers: a proof of concept study. Scientific Reports. 14(1). 18824–18824. 1 indexed citations
3.
4.
Murgić, Jure. (2022). Role of Androgen Receptor-Targeted Agents in Localized Prostate Cancer. Acta Clinica Croatica. 61(Suppl 3). 51–56.
5.
Murgić, Jure, et al.. (2022). Radiation Therapy for Cure or Palliation: Case of the Immunosuppressed Patient With Multiple Primary Cancers and Liver Transplant. International Journal of Radiation Oncology*Biology*Physics. 112(3). 581–582. 2 indexed citations
6.
Murgić, Jure. (2022). MRI-Guided Radiotherapy for Prostate Cancer: a New Paradigm. Acta Clinica Croatica. 61(Suppl 3). 65–70. 5 indexed citations
7.
Ulamec, Monika, et al.. (2021). New Insights into the Diagnosis, Molecular Taxonomy, and Treatment of Bladder Cancer. Acta Medica Academica. 50(1). 143–143. 17 indexed citations
8.
Ovčariček, Petra Petranović, Ana Fröbe, Frederik A. Verburg, et al.. (2020). Association of Triiodothyronine Levels With Prostate Cancer Histopathological Differentiation and Tumor Stage. Anticancer Research. 40(4). 2323–2329. 4 indexed citations
9.
Chua, Kevin Lee Min, Grace Kusumawidjaja, Jure Murgić, & Melvin L.K. Chua. (2017). Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy?. ESMO Open. 2(6). e000123–e000123. 5 indexed citations
10.
Murgić, Jure, Ivan Kruljac, Laura D’Alimonte, et al.. (2017). Dosimetric impact of inter-observer catheter reconstruction variability in ultrasound-based high-dose-rate prostate brachytherapy. Brachytherapy. 17(2). 306–312. 4 indexed citations
11.
Berlín, Alejandro, Ardalan E. Ahmad, Melvin L.K. Chua, et al.. (2017). Curative Radiation Therapy at Time of Progression Under Active Surveillance Compared With Up-front Radical Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 100(3). 702–709.
12.
Murgić, Jure, Peter Chung, Alejandro Berlín, et al.. (2016). Lessons learned using an MRI-only workflow during high-dose-rate brachytherapy for prostate cancer. Brachytherapy. 15(2). 147–155. 28 indexed citations
13.
Murgić, Jure, Hans T. Chung, Laura D’Alimonte, et al.. (2015). An Analysis of Inter-Observer Variability in Catheter Reconstruction and Dosimetric Implications in Ultrasound-Based High-Dose-Rate Brachytherapy for Prostate Cancer. Brachytherapy. 14. S96–S96. 1 indexed citations
14.
Johnson, Skyler B., Will Jackson, Jure Murgić, Felix Y. Feng, & Daniel A. Hamstra. (2013). Time to Nadir PSA. American Journal of Clinical Oncology. 38(5). 465–471. 8 indexed citations
15.
Murgić, Jure, Matthew H. Stenmark, Schuyler Halverson, et al.. (2012). The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer. Radiation Oncology. 7(1). 127–127. 7 indexed citations
16.
Kelava, Iva, et al.. (2012). Breast and gynecological cancers in Croatia, 1988-2008. Croatian Medical Journal. 53(2). 100–108. 8 indexed citations
17.
Soldić, Željko, et al.. (2011). Splenic irradiation in hematologic malignancies and other hematologic disorders--single institution experience.. PubMed. 50(1). 29–35. 5 indexed citations
18.
Murgić, Jure, et al.. (2009). Paget's disease in contralateral breast occuring 11 years after mastectomy for invasive ductal carcinoma.. PubMed. 33(1). 327–9. 1 indexed citations
19.
Murgić, Jure, et al.. (2008). Clinical guidelines development and usage: a critical insight and literature review: thyroid disease diagnostic algorithms.. PubMed. 32(4). 1283–90. 1 indexed citations
20.
Murgić, Jure, et al.. (2005). Transsphenoidal Encephalocele - Case Report. University of Zagreb University Computing Centre (SRCE). 44(4). 373–378. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026